Denilieukin diftitox vision loss is not posterior ischemic optic neuropathydoi:10.1080/10428190701843254Martin LubowNeuroOphthalmic Research GroupDeborah M. GrzybowskiNeuroOphthalmic Research GroupHamdy AwadNeuroOphthalmic Research GroupLeukemia & Lymphoma...
The ‘‘actuarial CVA’’ covers the expected loss, whilst the unexpected loss denotes the dif counterparty风险的量化的概要例证使用``保险方法"。 图显示损失的发行由于counterparty缺省在包括所有贸易的成熟时间范围。 意想不到的损失表示在此和最坏的损失之间的区别在某一信心, ``保险统计的CVA "补偿预计...
aSecond, I had early on (Lazarus 1966) drawn a distinction among three kinds of thress,harm, threat, and challenge (Lazarus 1966, 1981; Lazarus & Launier 1978; Lazarus & Folkman 1984). Harm refers to psychologica1 damage that had already been done---e.g. an irrevocable loss. Threat is...
题目【题目】12. We must prepare ourselves for the worst we are at a loss when meeting withdifficulties.A.afterB.beforeC.asD.since 相关知识点: 试题来源: 解析 【解析】12.B。此句意思是“在……之前做好最坏的准备”,故使用连词“before”。
问:你好,这几天小腹一直隐隐作痛,也恰好应该是来月经的时候,可一直却没有来,八月一号爱爱过一次,是体外xx,7.31是排卵日。在担心会不会是因为怀孕,但是咨询一下好像怀孕几率不大,那么为什么月经会推迟,和我这段时间冷饮吃多了有关系吗。我有些贫血(女,22岁) 答
Response to correspondence: Denileukin diftitox vision loss not due to posterior ischemic optic neuropathyNeuropilin-1acute myeloid leukemia cellsexpressionproliferationmigrationNeuropilin-1 (NRP-1) is a novel receptor of vascular endothelial growth factor (VEGF) and expressed in endothelial cells and ...
Denileukin diftitox (DD) is a novel immunotoxin approved in the USA for the treatment of relapsed CD25 positive cutaneous T-cell lymphoma (CTGL). Its use in other lymphoid malignancies and immu-nological conditions is being investigated in ongoing trials. At the time of FDA approval, it ...
Impact of intima re-intrusion and expansion within 100 minutes on late lumen loss in percutaneous coronary intervention for diffuse in-stent restenosisTunica IntimaHumansCoronary RestenosisRecurrenceProspective StudiesStentsTime FactorsAgedFemaleMaleIijima R, Ikari Y, Tsunoda T, Nakamura M, Hara K, ...
Sharma,H,Sen,S,Mathur,M,Bahadur,S,Singh,N.Combined evaluation of expression of telomerase, survivin, and anti-apoptotic Bcl-2 family members in relation to loss of differentiation and apoptosis in human head and neck cancers.Head and Neck. 2004...
Bain, S.; Shalmi, M.; Korsgaard, N., 1997: Levormeloxifene, a non-steroidal estrogen receptor therapeutic, prevents bone loss, reduces serum cholesterol, and has differentiated uterine, effects in the ovariectomized ratdoi:10.1016/S0378-5122(97)81283-2S....